Charles River Laboratories CRL Stock options excluded as their inclusion would be anti-dilutive (in shares)
Stock options excluded as their inclusion would be anti-dilutive (in shares) at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's stock options excluded as their inclusion would be anti-dilutive (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's stock options excluded as their inclusion would be anti-dilutive (in shares)?
- Charles River Laboratories (CRL) reported stock options excluded as their inclusion would be anti-dilutive (in shares) of 615K in Q1 2026.
- How has Charles River Laboratories's stock options excluded as their inclusion would be anti-dilutive (in shares) changed year-over-year?
- Charles River Laboratories's stock options excluded as their inclusion would be anti-dilutive (in shares) decreased by 35.8% year-over-year, from 958K to 615K.
- What is the long-term trend for Charles River Laboratories's stock options excluded as their inclusion would be anti-dilutive (in shares)?
- Over 2 years (2023 to 2025), Charles River Laboratories's stock options excluded as their inclusion would be anti-dilutive (in shares) has grown at a 35.9% compound annual growth rate (CAGR), from 2.2M to 4.1M.
- What does stock options excluded as their inclusion would be anti-dilutive (in shares) mean?
- The number of potential common shares, such as stock options or restricted stock units, excluded from the diluted earnings per share calculation because their inclusion would be anti-dilutive. This occurs when the exercise price is higher than the average market price.